Evaluation of the PneumRx Lung Volume Reduction Coil to Treat Emphysema
Evaluation of the PneumRx, Inc. Lung Volume Reduction Coil for the Treatment of Emphysema
Sponsor: Boston Scientific Corporation
A NA clinical study on Emphysema, this trial is completed. The trial is conducted by Boston Scientific Corporation and has accumulated 8 data snapshots since 2008. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jun 2023 — Jul 2024 [monthly]
Completed NA
-
Sep 2021 — Jun 2023 [monthly]
Completed NA
-
Jan 2021 — Sep 2021 [monthly]
Completed NA
▶ Show 3 earlier versions
-
Sep 2019 — Jan 2021 [monthly]
Completed NA
Phase: PHASE1_PHASE2 → NA
-
Jun 2018 — Sep 2019 [monthly]
Completed PHASE1_PHASE2
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE1_PHASE2
First recorded
Jan 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Boston Scientific Corporation
- PneumRx, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .